SEC 13F Intelligence

Neville Rodie & Shaw Inc / LLY

Neville Rodie & Shaw Inc’s Eli Lilly & Co Position

Does Neville Rodie & Shaw Inc own Eli Lilly & Co (LLY)? Yes — 17.2K shares worth $21M (+1.34% of its 13F portfolio) as of Q2 2026, down from 20.8K shares the prior filed quarter.

Position Value
$21M
Q2 2026
Shares
17.2K
% of Portfolio
+1.34%
Quarters Held
25
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $255,000Q4 ’18Q1 ’19: $290,000Q2 ’19: $244,000Q1 ’21: $224,000Q2 ’21: $275,000Q2 ’21Q3 ’21: $277,000Q4 ’21: $331,000Q1 ’22: $351,000Q2 ’22: $389,000Q2 ’22Q3 ’22: $412,000Q4 ’22: $710,000Q1 ’23: $903,000Q2 ’23: $6MQ2 ’23Q3 ’23: $7MQ4 ’23: $8MQ1 ’24: $12MQ2 ’24: $14MQ2 ’24Q3 ’24: $13MQ4 ’24: $12MQ1 ’25: $12MQ2 ’25: $12MQ2 ’25Q3 ’25: $11MQ4 ’25: $21MQ1 ’26: $19MQ2 ’26: $21MQ2 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202617.2K$21M+1.34%
Q1 202620.8K$19M+1.39%
Q4 202519.2K$21M+1.45%
Q3 202514.1K$11M+0.78%
Q2 202516.0K$12M+0.92%
Q1 202515.1K$12M+0.98%
Q4 202415.0K$12M+0.85%
Q3 202414.9K$13M+0.97%
Q2 202415.4K$14M+1.06%
Q1 202415.2K$12M+0.90%
Q4 202314.4K$8M+0.69%
Q3 202313.0K$7M+0.62%
Q2 202312.6K$6M+0.51%
Q1 20232.6K$903,000+0.08%
Q4 20221.9K$710,000+0.07%
Q3 20221.3K$412,000+0.04%
Q2 20221.2K$389,000+0.03%
Q1 20221.2K$351,000+0.03%
Q4 20211.2K$331,000+0.02%
Q3 20211.2K$277,000+0.02%
Q2 20211.2K$275,000+0.02%
Q1 20211.2K$224,000+0.02%
Q2 20192.2K$244,000+0.03%
Q1 20192.2K$290,000+0.03%
Q4 20182.2K$255,000+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neville Rodie & Shaw Inc’s full portfolio or all institutional holders of LLY.